Print

WHO declares Ebola outbreak in DRC and Uganda a PHEIC; India issues travel advisory

In light of the reported outbreaks of Ebola Disease in the Democratic Republic of the Congo (DRC) and Uganda, the World Health Organization (WHO), under the International Health Regulations (IHR), 2005, on 17 May 2026, determined the situation to be a Public Health Emergency of International Concern (PHEIC).
The Africa Centres for Disease Control and Prevention (Africa CDC) has also officially declared the ongoing outbreak of Bundibugyo strain Ebola Virus Disease affecting the Democratic Republic of the Congo and Uganda as a Public Health Emergency of Continental Security (PHECS).

Further, the WHO IHR Emergency Committee on 22 May 2026 issued temporary recommendations to strengthen disease surveillance at Points of Entry to “detect, assess, report and manage travellers with unexplained febrile illness arriving from areas with documented Bundibugyo virus detection” while also “discouraging travel to areas with documented Bundibugyo virus detection”.

Countries bordering the Democratic Republic of the Congo and Uganda, including South Sudan, are assessed to be at high risk of disease transmission.

Ebola Disease is a viral haemorrhagic fever caused by infection with the Bundibugyo virus strain of Ebola Virus. It is a serious disease with a high mortality rate. At present, no vaccines or specific treatments have been approved to prevent or treat Ebola Disease caused by the Bundibugyo virus strain.

India has not reported any case of Ebola Disease caused by the Bundibugyo virus strain.

In view of the evolving situation in the Democratic Republic of the Congo and other affected countries, and in line with WHO’s recommendations, Government of India advises all Indian citizens to avoid non-essential travel to the Democratic Republic of the Congo, Uganda and South Sudan until further notice.

Indian citizens currently residing in or travelling to these countries are advised to strictly follow public health guidance issued by local authorities and maintain heightened precautions.

RELATED ARTICLES

7 mins ago | AstraZeneca

NIPER Raebareli, AstraZeneca partner to strengthen 25 clinical trial sites beyond metros

The National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, and AstraZeneca India on Wednesday signed a partnership to strengthen clinical research capabilities across 25 emerging research locations, expanding trial capacity b...

22 mins ago | Bahrain

Indian Navy to Hand Over Command of Combined Task Force 154 in Bahrain

The Indian Navy is scheduled to hand over command of Combined Task Force 154 (CTF 154) at a ceremony in Manama, Bahrain, on October 14, marking the completion of its first-ever command of a task force under the Combined Maritime Forces (CMF). CTF 15...

32 mins ago | disability pension

Cabinet approves Rs 53,428 crore social assistance programme, expands disability pension eligibility

The Union Cabinet on Wednesday approved the continuation of the National Social Assistance Programme for five years, from 2026–27 to 2030–31, with an outlay of ₹53,428 crore, while expanding disability pension eligibility and increasing assista...